Benzinga | Mar 12, 2021 08:58AM EST

Wolfe Research Initiates Coverage On Global Blood Therapeutics with Outperform Rating, Announces Price Target of $67

Wolfe Research analyst Akash Tewari initiates coverage on Global Blood Therapeutics (NASDAQ:GBT) with a Outperform rating and announces Price Target of $67.